TXG analyst estimates
10x Genomics (TXG) analyst ratings, the average price target and its range, and every firm's latest call.
TXG analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 13, 2026 | Stifel Nicolaus | 10X Genomics (TXG) PT Raised to $70 at TD Cowen | $70.00 |
| Oct 12, 2026 | Canaccord Genuity | 10x Genomics price target raised to $100 from $60 at Canaccord | $100.00 |
| Oct 12, 2026 | Morgan Stanley | 10x Genomics price target raised to $70 from $40 at Morgan Stanley | $70.00 |
| Oct 7, 2026 | Barclays | 10x Genomics price target raised to $110 from $52 at Barclays | $110.00 |
| Sep 29, 2026 | Leerink Partners | 10x Genomics price target raised to $90 from $40 at Leerink | $90.00 |
| Sep 28, 2026 | Piper Sandler | 10x Genomics price target raised to $80 from $47 at Piper Sandler | $80.00 |
| Sep 28, 2026 | Argus Research | 10x Genomics initiated with a Buy at Argus | $110.00 |
| Sep 9, 2026 | UBS | 10x Genomics assumed with a Neutral at UBS | $68.00 |
| Sep 1, 2026 | RBC Capital | RBC Capital Starts 10X Genomics (TXG) at Sector Perform | $70.00 |
| Aug 12, 2026 | Stephens | 10x Genomics price target raised to $65 from $50 at Stephens | $65.00 |
| Aug 10, 2026 | Canaccord Genuity | 10X Genomics (TXG) PT Raised to $60 at Canaccord | $60.00 |
| Aug 10, 2026 | Piper Sandler | 10x Genomics price target raised to $47 from $42 at Piper Sandler | $47.00 |
| Aug 7, 2026 | Stifel Nicolaus | 10x Genomics price target raised to $50 from $25 at Stifel | $50.00 |
| Aug 7, 2026 | Morgan Stanley | 10x Genomics price target raised to $40 from $37 at Morgan Stanley | $40.00 |
| Jul 17, 2026 | Leerink Partners | 10x Genomics price target raised to $40 from $23 at Leerink | $40.00 |
- 15 firms rate TXG: 6 buy, 9 hold, 0 sell.
- The average price target is $83.30 from 10 analysts, from $65.00 to $110.00.
Updated 2026-11-02 17:52 UTC